News

Ravi Jandhyala, Consultant Pharmaceutical Physician at Medialis and an expert in rare disease patient registries, discusses how to overcome clinical trial registry challenges.

With radio, billboard, TV, and digital advertisements being left in the dust, additional engagement from influencer communities are more likely to be reach patients.

Allyson Gage, Chief Medical Officer at Cohen Veterans Bioscience talks about her perspectives on platform trial design.

Click the title above to open the Applied Clinical Trials March 2020 issue in an interactive PDF format.

The trends that seem to be garnering the most discussion today among clinical trial management and operations professionals.

Teenagers with cancer could benefit from a proposed initiative to lower the age barrier for participation in trials for new oncology drugs.

A compilation of recently released news briefs that pertain to the clinical trials industry.

Study holds new benchmarks and improvement opportunities.

Jennifer Bradford, head of data science for Phastar, shares data and analytics-related learnings from a diverse career journey in research

With the final approval and release of ICH E9 (R1), clinical trial sponsors should prepare to include estimands in their protocols as well as their statistical design documents and study reports.